Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.20.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Apr. 20, 2020
May 31, 2019
Apr. 30, 2017
Jun. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Exercise price per share       $ 0.50    
Agrarian Technologies LLC [Member]            
Renewal term for agreement   10 years        
Payments for royalties including minimum annual guarantees   $ 30,000        
license fee       $ 30,000    
Employment Agreement [Member] | CEO [Member]            
Base salary     $ 350,000      
Employment Agreement [Member] | President and General Counsel [Member]            
Base salary     220,000      
Services Agreement [Member]            
Number of warrants           150,000
Average remaining term in years           5 years
Exercise price per share           $ 0.04
License Agreement [Member]            
license fee   $ 30,000   30,000 $ 15,000  
Payments for milestone $ 60,000          
Other expense reimbursements $ 150,000          
Equity method investment ownership percentage 5.00%          
Royalty percentage 4.50%          
License Agreement [Member] | Maximum [Member]            
Royalty percentage 50.00%          
License Agreement [Member] | QSAM Therapeutics Inc [Member]            
license fee       30,000    
Payments for milestone     60,000      
Other expense reimbursements     $ 150,000 $ 60,000    
Equity method investment ownership percentage 5.00%   5.00%      
Royalty percentage     4.50%      
License Agreement [Member] | QSAM Therapeutics Inc [Member] | Maximum [Member]            
Royalty percentage     50.00%